Milestone Pharmaceuticals, Inc. (MIST)
1.04
-0.02
(-1.42%)
USD |
NASDAQ |
Aug 24, 16:00
1.05
+0.01
(+0.96%)
After-Hours: 20:00
Milestone Pharmaceuticals Market Cap : 129.48M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 129.48M |
| August 21, 2026 | 131.35M |
| August 20, 2026 | 128.23M |
| August 19, 2026 | 134.46M |
| August 18, 2026 | 133.21M |
| August 17, 2026 | 136.95M |
| August 14, 2026 | 136.95M |
| August 13, 2026 | 133.21M |
| August 12, 2026 | 140.06M |
| August 11, 2026 | 158.11M |
| August 10, 2026 | 156.87M |
| August 07, 2026 | 151.89M |
| August 06, 2026 | 139.00M |
| August 05, 2026 | 134.87M |
| August 04, 2026 | 137.82M |
| August 03, 2026 | 131.93M |
| July 31, 2026 | 130.75M |
| July 30, 2026 | 135.46M |
| July 29, 2026 | 122.51M |
| July 28, 2026 | 126.04M |
| July 27, 2026 | 133.11M |
| July 24, 2026 | 136.64M |
| July 23, 2026 | 141.35M |
| July 22, 2026 | 140.18M |
| July 21, 2026 | 144.89M |
| Date | Value |
|---|---|
| July 20, 2026 | 139.00M |
| July 17, 2026 | 139.59M |
| July 16, 2026 | 146.07M |
| July 15, 2026 | 149.60M |
| July 14, 2026 | 153.13M |
| July 13, 2026 | 150.78M |
| July 10, 2026 | 150.78M |
| July 09, 2026 | 154.31M |
| July 08, 2026 | 143.71M |
| July 07, 2026 | 151.95M |
| July 06, 2026 | 155.49M |
| July 02, 2026 | 155.49M |
| July 01, 2026 | 155.49M |
| June 30, 2026 | 157.84M |
| June 29, 2026 | 156.67M |
| June 26, 2026 | 146.07M |
| June 25, 2026 | 147.24M |
| June 24, 2026 | 149.60M |
| June 23, 2026 | 153.13M |
| June 22, 2026 | 154.31M |
| June 18, 2026 | 153.13M |
| June 17, 2026 | 154.31M |
| June 16, 2026 | 151.95M |
| June 15, 2026 | 154.31M |
| June 12, 2026 | 149.60M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| InMed Pharmaceuticals, Inc. | 4.739M |
| NervGen Pharma Corp. | 212.83M |
| Clearmind Medicine, Inc. | 1.712M |
| Lexaria Bioscience Corp. | 17.42M |
| Target Group, Inc. (Canada) | 0.6417M |
Market Cap Related Metrics
| PS Ratio | 52.34 |
| Price to Book Value | 7.107 |
| Price | 1.04 |
| Earnings Yield | -66.71% |